CORC  > 复旦大学上海医学院
Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report
Dong, Liang; Xia, Jingwen; Zhang, Jing; Zhang, Yuanyuan; Zhu, Ning; Zhang, Peng; Zhang, Youzhi; Zhang, Xiujuan; Li, Shengqing
刊名BMC PULMONARY MEDICINE
2018
卷号18
关键词Lung adenocarcinoma ROS1 rearrangement Pemetrexed Crizotinib Lorlatinib
ISSN号1471-2466
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3603840
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Dong, Liang,Xia, Jingwen,Zhang, Jing,et al. Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report[J]. BMC PULMONARY MEDICINE,2018,18.
APA Dong, Liang.,Xia, Jingwen.,Zhang, Jing.,Zhang, Yuanyuan.,Zhu, Ning.,...&Li, Shengqing.(2018).Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report.BMC PULMONARY MEDICINE,18.
MLA Dong, Liang,et al."Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report".BMC PULMONARY MEDICINE 18(2018).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace